Rhode Island Issues New Guidelines on the Fair Use of Aerial Imagery in Homeowners Insurance Decisions
RI| The Rhode Island Department of Business Regulation issued Bulletin 2025-3 to clarify the proper use of aerial and satellite imagery by homeowners insurers in underwriting, policy nonrenewals, and claims settlements. The bulletin stresses that imagery must be clear, accurate, current (less than 15 months old), and cannot alone justify adverse actions unless there is […]
New Surplus Lines Insurer Approved by Arizona Surplus Lines Association
AZ| Bulletin 2025-08, issued by the Surplus Lines Association of Arizona, announces the addition of Calais Reciprocal Insurance Exchange, NAIC #17805, to their list of approved unauthorized surplus lines insurers. Effective July 30, 2025. Click here to see AZ SLA Bulletin 2025-08
Vermont Requires No-Cost Diagnostic Breast Imaging Coverage Starting January 2026.
VT| The Vermont Department of Financial Regulation issued Insurance Bulletin #235 on August 15, 2025, clarifying the enforcement timeline for newly mandated health insurance coverage of diagnostic breast imaging under state law changes. Specifically, Act 94 of 2023 requires insurers to provide coverage for diagnostic mammography and breast imaging with no member cost-sharing, effective for […]
Connecticut Insurance Department Updates MH/SUD Parity Reporting: New Annual Compliance Guidelines Effective March 2026
CT| Connecticut Insurance Department Bulletin MC-24B updates annual reporting requirements for carriers delivering or issuing health insurance policies in Connecticut concerning mental health and substance use disorder (MH/SUD) parity compliance, effective March 1, 2026, and replaces Bulletin MC-24-A. This policy requires carriers to review and report on their non-quantitative treatment limitation (NQTL) practices ensuring parity […]
New Mexico Bans Prior Authorization & Step Therapy for Critical Medications in 2025 (Updated)
NM| Effective July 1, 2025, New Mexico Senate Bill 39 amends the Prior Authorization Act to prohibit prior authorization and step therapy for FDA-approved drugs (including off-label use) used to treat autoimmune disorders, cancer, substance use disorders, and rare diseases/conditions. Key requirements include: Click here to see UPDATED Bulletin 2025-005
Alabama DOI Launches Liability Insurance Coverage Data Call to Study Claims Costs
AL| The Alabama Department of Insurance is conducting a Liability Insurance Coverage data call to assess the impact of such coverage on insurance claims costs. The data call applies to all insurers licensed in Alabama that provide personal and commercial automobile, personal and commercial umbrella, commercial general liability (excluding homeowners), and medical or other professional […]
Insurers in NM Face Strict Filing and Compliance Demands for Value-Added Offerings, Effective August 2025
NM| Bulletin 2025-006, from the New Mexico Office of Superintendent of Insurance (OSI), effective August 14, 2025, outlines the requirements for insurers who wish to offer value-added products or services with insurance policies in New Mexico. It clarifies that insurers may provide such offerings at no or reduced cost—even if not specified in the insurance […]
Major Medicaid and QHP Updates: No Cost-Sharing for Behavioral Health Services and Stronger Out-of-Network Safeguards in New Mexico
NM| Bulletin 2025-007, from the New Mexico Office of Superintendent of Insurance, outlines new and revised requirements for standardized language, administrative data submissions, and discontinuation notices for issuers offering major medical plans and Qualified Health Plans (QHPs) in New Mexico. The bulletin emphasizes integration of updated prior authorization requirements, maintenance of administrative data filings, and […]
Mississippi Announces Address Change for an Approved Non-Admitted Insurer
MS| Bulletin 2025-20, issued by the Mississippi Surplus Lines Association, announces the address change for approved non-admitted insurer, Amherst Specialty Insurance Company, effective August 14, 2025. Home Office: 14001 Dallas Pkwy Ste 700Dallas, TX 75240-134 Mailing Address: 14001 Dallas Pkwy Ste 700Dallas, TX 75240-134 Click here to see MSLA Bulletin 2025-20
Delaware Tightens Oversight of Property & Casualty Insurer Arbitration Compliance
DE| The Delaware Department of Insurance’s Bulletin No. 155 reminds all property and casualty carriers operating in Delaware of their obligations under 18 DE Admin. Code § 901 regarding arbitration petitions. Carriers must respond to properly filed arbitration petitions within 20 business days and pay the required respondent filing fee, ensuring petitions are promptly routed […]